Healthcann

🔬💧 We've got our very own Healthcann LEGO set! Imagine a mini-lab made of blocks, where anyone can be a scientist conducting research 👨🏻‍🔬

Well, it's just a joke for now! 😂 But who knows what the future holds? Maybe one day we'll make our own!

🌿 Nadchodzi III Konferencja "Innowacyjne Terapie Konopne" organizowana przez Dr.Max Polska!

📅 Kiedy? 9 grudnia - zapisz tę datę!

🌐 Gdzie? Online, wygodnie z Twojego domu.

🤔 O czym? Odkryjemy postępy, kontrowersje i nowości dotyczące medycznej marihuany w Polsce. W panelu dyskusyjnym między innymi udział weźmie Grzegorz Kiełbowicz, PhD, a debatę poprowadzi Agata Młynarska.

🎓 Dla kogo? Dla pacjentów, specjalistów medycznych i każdego, kto chce zgłębić ten temat.

🔬 Spotkanie Ekspertów: Zgromadzimy lekarzy i specjalistów z całego świata, aby dyskutować o dostępności i możliwościach leczenia medyczną marihuaną w Polsce.

🌍 Międzynarodowe Perspektywy: Wybitni eksperci, w tym dr Silviu Brill z Izraela, podzielą się swoją wiedzą i doświadczeniem.

💬 Debata z Ekspertami: Dyskusja na temat kontrowersji i postępów w terapii konopnej, w której wezmą udział różne środowiska - medyczne, pacjenckie, polityczne i biznesowe.

👋🏻 Dołącz do nas! To wyjątkowa okazja do zdobycia wiedzy i zrozumienia aktualnej sytuacji medycznej marihuany w Polsce. Bądź na bieżąco z innowacjami w terapii konopnej.

✌🏻 Appreciation for the "Wrocław jest przedsiębiorczy" Conference

We are profoundly grateful for the opportunity to have participated in the 2nd "Wrocław jest przedsiębiorczy" Conference, hosted at the WPT - Wrocławski Park Technologiczny. This event provided a fantastic platform to delve into digital transformation, innovation, and corporate social responsibility.

🏬 Special commendation goes to the WPT - Wrocławski Park Technologicznyfor their outstanding organization and for creating an inspiring environment for all participants and speakers. Your efforts in fostering entrepreneurship and innovation in the region are truly valuable.

👨🏻‍💼 We extend our thanks to Grzegorz Kiełbowicz, PhD and all the panelists for their insightful contributions. Your expertise and perspectives significantly enriched discussions

😁 A heartfelt thank you to everyone involved for creating such a productive and inspiring setting for the exchange of ideas and experiences.

🌿 Excellence in Cannabinoid Education: Celebrating a Noteworthy Course At Healthcann, we’re always on the lookout for exceptional educational programs that can enhance our expertise, and the Online Medical Cannabis Course by the Multidisciplinary Center for Cannabinoid Research at The Hebrew University of Jerusalem, Yissum Technology Transfer Company of the Hebrew University stands out as a premier learning experience.

Its curriculum is shaped by some of the sharpest minds in cannabinoid research, including colleagues of the legendary Raphael Mechoulam. This makes it a beacon for those seeking to understand the full potential of cannabis-based therapies and a testament to the legacy of a pioneer.

We had the pleasure of having Agnieszka Teodoru, a member of our team, graduate from this esteemed course. Her accomplishment underscores our dedication to fostering an environment where learning and leading in cannabinoid innovation go hand in hand.

To our peers and colleagues considering specialized training in medical cannabis: this course represents a significant opportunity to gain a competitive edge in the industry.

🔎"Czym jest dziś innowacja?" To pytanie będziemy zgłębiać na II Konferencji 'Wrocław jest przedsiębiorczy' już 23 listopada!

Dołącz do nas i posłuchaj Grzegorza Kiełbowicza, PhD z Healthcann oraz innych ekspertów, jak dzielą się swoimi spojrzeniami.

👩‍💼 Magdalena Irek is the diligent Office Manager at Healthcann S.A. With an impressive track record spanning over 20 years in marketing, she is a seasoned expert in administration, customer service, and the strategic implementation of sales.

📊 At Healthcann since October 2022, Magdalena has been instrumental in streamlining the management office's operations, ensuring flawless document flow, and optimizing billing procedures. Her marketing prowess not only complements her daily tasks but also elevates the company's brand presence and outreach.

🔐 Being proficient in data security, Magdalena upholds the RODO compliance standards and possesses the vital competencies to serve as the Personal Data Inspector.

💼 Her vast experience empowers her to seamlessly juggle diverse roles within the company, ensuring efficiency and contributing to Healthcann's growing success.

Sylwia Ciałek is a Research & Development Specialist at Healthcanna. A proud alumnus of Wrocław University of Life Sciences, she specialized in biotechnology and displayed keen interest in cannabinoids. This passion was ignited while she was engrossed in her engineering thesis, which explored the novel concept of microbial CBD production within yeast cells.

🌍 Sylwia's commitment to global learning is evident. Twice, she ventured through the Erasmus program, granting her the privilege of academic exposure at Ort Bradue College in Israel and a hands-on internship experience at the renowned CNIC in Madrid. These international endeavors enriched her expertise in cell biology and molecular biology.

🔬 With a penchant for integrating various scientific disciplines, Sylwia finds her niche in marrying chemistry with molecular biology techniques. She believes that this intersection paves the way for pioneering advancements in modern drug and dietary supplement technologies.

📚 At Healthcanna, Sylwia's work revolves around conceptualizing and crafting innovative cannabinoid delivery systems.

🤩 We are pleased to announce that Healthcann will be participating in and partnering with the III Conference on Innovative Cannabis Therapies, organized by Dr.Max Polska!

🌎 This exceptional event gathers medical experts from Poland and around the world to discuss the accessibility and potential of medical cannabis treatment in Poland. During the conference, distinguished medical practitioners will share their knowledge regarding the use of cannabinoids in medicine and discuss current regulations and clinical research findings.

🎙 Our esteemed CEO, Dr. Grzegorz Kiełbowicz, will be sharing insights as a panelist in a compelling debate. Dive deep into the topics of therapy accessibility, the bioavailability of cannabinoids, and our cutting-edge AdvanDrop® technology. The session will be brilliantly moderated by the renowned Agata Młynarska.

A heartfelt thanks to Anita Jeglińska for the gracious invitation.

📅 Mark your calendars! Can't wait to engage with all of you at the conference.

👨🏻‍🔬 Radosław Gniłka, PhD is the Director of R&D at Healthcann. He holds a PhD in Biotechnology from the University of Life Sciences in Wroclaw, Department of Chemistry, and is an expert in the chemical and microbiological transformation of natural compounds to enhance their biological activity.

🔬 He has 5 years of experience in the nutraceutical and functional food industry, where he was involved in quality control and product launches on domestic and foreign markets. His chapter at tukasiewicz-PORT stands out, marked by dynamic research on innovative green solvent technology from PLA waste. Later, as head of the Spectroscopic and Chemical Research Laboratory, he tried to bridge the complex worlds of science and business.

📈 At Healthcann, as head of R&D, he focuses on achieving the objectives set out in the milestones of the acquired R&D projects. He sees the research and development phase as an intermediate stage that culminates in a finished product available on the market. He has strong analytical skills and uses modern data science tools in his work.

🚲 Outside the lab, he's an avid cycling enthusiast - passionately journeying on lengthy bicycle trips. His intellectual curiosities include climate change, quantum physics and green chemistry, particularly deeply eutectic solvents.

🎓Paweł Mituła, PhD is the Chief Technology Officer and Co-Founder of Healthcann. Trained as a biotechnologist and chemist ,he earned his PhD in Biotechnology from the University of Life Sciences in Wrocław.

🧪Before his tenure at Healthcann, Paweł served in significant roles at Synthos and PCC Rokita, notable entities in the chemical industry. During his time at Synthos, he was responsible for the development of liposomal technology, a critical component in the drug delivery sector. His roles varied from Research & Development Specialist to Project Coordinator , thereby acquiring a comprehensive understanding of the sector. He played a key role in the creation of new product portfolios and ensured a successful transition from laboratory-scale to high-volume commercial production.

🔬Paweł also coordinated advanced biotechnological projects at companies such as Skotan and PureBiologics. Here, he led the development of innovative bacteriophage encapsulation systems, designed to combat the ever-growing issue of multidrug-resistant bacteria.

🤝Besides Healthcann, Mituła and our CEO Grzegorz co-founded Sovigo, a firm focused on creating precise drug delivery systems to improve care for patients, particularly those with gastrointestinal diseases.

🌎As the CTO at Healthcann, Paweł spearheads the company's technological vision and oversees project portfolio management. His expertise in chemical synthesis, process scaling, and process engineering is pivotal in transforming Healthcann's innovative ideas into market-ready solutions.

👩🏻‍💼 Agnieszka Teodoru is the Chief Operating Officer and Co-Founder of Healthcann. A seasoned entrepreneur with 18 years of business experience, she brings a broad business perspective and invaluable knowledge to the operations of the company.

🌐 Agnieszka’s journey in the cannabis industry began in Israel in 2018, a country widely recognized for its progressive approach towards medical cannabis. During her time there, she gained direct access to international business contacts and comprehensive knowledge of the cannabis industry.
Backed by her unique experience and deep understanding of the cannabis industry, she founded the CannMedica Foundation. The organization is committed to promoting reliable and comprehensive cannabis knowledge among doctors, pharmacists, and medical personnel, thereby bridging the information gap in the healthcare community.

📈 Before joining Healthcann, Agnieszka successfully led various high-profile initiatives in the event industry. Her company collaborated with world-renowned brands such as Coca Cola, Douglas, LVMH Louis Vuitton Moet Hennessy, the Polish Football Association, Ryan AIR, and Mercedes Benz.

🛠️ At Healthcann, Agnieszka directs the coordination of the company's internal departments and plays a vital role in strategic areas of the company's development. Her extensive experience in team management, product development, and branding positions Healthcann for rapid growth and market leadership.

🥼 Grzegorz Kiełbowicz, PhD is the Chief Executive Officer and Co-Founder of Healthcann. Holding a PhD in Biotechnology from Wrocław University of Life Sciences, he is an expert in nanomedicine and advanced drug delivery systems, with demonstrated leadership built upon more than a decade of diverse industry experience.

📈 Before founding Healthcann, Grzegorz made significant contributions to the R&D, quality, and regulatory operations in the pharmaceutical sector. His tenure at SteriPack was marked by successful collaborations with industry giants such as Merck, Jansen, Stryker, Ferrosan, and Biotronik.

💡 Grzegorz is also a Co-Founder of Sovigo, a company committed to innovating precise drug delivery systems for improved patient care, particularly for those suffering from gastrointestinal diseases.

🔬 As CEO, Grzegorz leverages his scientific acumen and strategic vision to guide the company. He oversees the implementation of current plans and shapes future strategies, ensuring that Healthcann continues to drive innovation in the biopharmaceutical sector.

We are a unique biotechnology company in Europe that develops, patents and commercializes innovative technologies that make the active compounds from h**p (CBD, CBG, THC and more) delivered to the body work faster, more effectively and longer. We use these technologies to create new innovative products, previously unavailable on the market, whose speed and effectiveness are always confirmed by scientific research.

Our broad portfolio of technologies, products and services can be used by h**p, pharmaceutical and food companies around the world.

Thanks to our core competencies, which include chemistry, biotechnology and process engineering, as well as manufacturing and laboratory capabilities, we are able to meet the specific needs, even of the largest and most complex projects. This gives us a tremendous competitive advantage and powerful capabilities to pursue international contracts, either as a supplier of intermediate products (such as Advandrop® technology) or as a "private lable" manufacturer.

In this episode:
1:34 What does Healthcann do?
3:22 The market for h**p products.
7:34 The evolution of h**p products - Cannabis 3.0.
10:46 Forms of supply of h**p products.
12:39 Forms of h**p products and their effectiveness.
13:28 AdvanDrop technology - a novel nano-dissolution method.
22:28 Healthcann S.A. business model.
31:15 Our goals for the future.
34:27 Q&A session

Healthcann S.A. - plany, wizja, przyszłość - rozwój biotechnologii w branży konopnej. Healthcann to partner w rozwoju i dostawca rozwiązań dla całego przemysłu konopnego.Jesteśmy unikatową na skalę europejską spółką biotechnologiczną, która op...

Cannabidiol (CBD) is the best studied substance found in h**p next to THC. CBD has attracted a great deal of interest for many years, and scientific publications on it are increasing every year. This is not surprising.

The compound shows a number of documented therapeutic effects with a very large margin of safety in its use.

The benefits of using CBD are many and varied. What is perhaps most significant is that cannabidiol does not have an addictive effect. It interacts with CB1 receptors in the brain, but is their antagonist.

Thanks to this mechanism, it allows to neutralize the psychoactive effects of tetrahydrocannabinol on the human body. The patient does not experience a high, euphoria or changes in consciousness. CBD is specifically used in h**p products containing THC to achieve the desired therapeutic effects, without exposing the patient to the possibility of psychological dependence.

Healthcann, a Wroclaw-based biotechnology company, has been selected in a competition by the National Research and Development Center to develop technology that will improve the absorption of cannabis products into the body, which are used to treat a number of neurological conditions. The research work is expected to be completed by the end of 2023.

"The primary goal is research on h**p compounds. However, in practice, we have a much broader goal. The research we are conducting is about to start a new era in the area of prevention and health care. Our proposed technology is expected to help treat chronic diseases more effectively, for example by improving the absorption of health substances, so-called nutraceuticals." - says Dr. Grzegorz Kiełbowicz, CEO of Healthcann S.A.

„ZA UNIJNE PIENIĄDZE WROCLAWSKA FIRMA BADA WCHŁANIANIE LEKÓW I SUPLEMENTÓW NA BAZIE KONOPI”. Wroclaw.pl – Healthcann Date: 19 września 2022 Posted by: admin Category: Bez kategorii „ZA UNIJNE PIENIĄDZE WROCLAWSKA FIRMA BADA WCHŁANIANIE LEKÓW I SUPLEMENTÓW NA BAZIE KONOPI”. Wroclaw.pl Narodowe Centrum Badań i Rozwoju wybrało wrocławską firmę Healthcann S.A. do oprowadzenia badań nad nową technologi....

BUSINESS TIGERS is the most prestigious award for outstanding personalities of the business world. Today we would like to remind you of this unique award, which our company received in December 2022. The award is given to enterprising men and women who are distinguished by their unparalleled talent, passion and steadfastness in pursuit of their goals. The winners are individuals who are role models and inspirations for those around them. The title of BUSINESS TYGRYS is a confirmation of the success achieved, honoring past achievements, but also a motivation for further growth.

The mission of the organizers is to recognize and support outstanding entrepreneurs, business owners and executives, thereby promoting positive role models in the business world. Distinction in the competition is a certification of compliance with the highest standards and confirmation of business ethics.

Such a moment, can happen only once. We are extremely pleased that our achievements have been recognized and during the gala ceremony on 9.12.2022 we received the BUSINESS TIGER. This unique statuette covered with 24 carat gold can be received only once in a lifetime.

Gala TYGRYSY BIZNESU 2022 - Dr P. Mituła, A. Teodoru , Dr G.Kiełbowicz, Healthcann S.A. TYGRYSY BIZNESU to najbardziej prestiżowe wyróżnienie dla znakomitych osobowości świata biznesu. Nagroda jest przyznawana przedsiębiorczym kobietom i mężczyz...

Wroclaw-based Healthcann has been selected in the "Fast Track" competition of the National Center for Research and Development to conduct research on a new technology for delivering compounds to the body.

- Wrocław-based biotechnology company Healthcann is carrying out a research project subsidized by the NCRD
- The project, which has already begun, will be completed by the end of 2023
- The new solution will increase the absorption (bioavailability) of medicinal and health-promoting substances available on the market

https://healthcann.eu/index.php/2022/08/16/pracuja-nad-nowa-metoda-zwiekszania-wchlanialnosci-lekow-i-suplemtow/

Healthcann S.A. has been selected by the National Research and Development Center to research a cutting-edge technology. It will allow better absorption of h**p-based medicines and supplements. This will be helped by EU money.

The Wroclaw-based company will develop technology that will improve the absorption into the body of h**p products, which are used in the treatment of many neurological conditions. The research work is scheduled to be completed by the end of 2023.

„WROCŁAWSKA FIRMA BADA LEKI KONOPNE. PROJEKT DOFINANSOWANY ZE ŚRODKÓW UNIJNYCH”. Tudolnyslask.info – Healthcann Date: 20 września 2022 Posted by: admin Category: Bez kategorii „WROCŁAWSKA FIRMA BADA LEKI KONOPNE. PROJEKT DOFINANSOWANY ZE ŚRODKÓW UNIJNYCH”. Tudolnyslask.info Firma Healthcann S.A. została wybrana przez Narodowe Centrum Badań i Rozwoju do badań nad nowoczesną technologią. Pozwoli on...

"One of the most growing markets today is the h**p and CBD market. In Europe alone, it is expected to reach a value of more than $3 billion this year. And it is in this backyard, still growing, that the Wroclaw-based startup Healthcann, which won the competition of the National Research and Development Center, wants to conquer. All thanks to the studio's proprietary technology - AdvanDrop"

WROCŁAWSKI STARTUP CHCE NAMIESZAĆ NA RYNKU KONOPI. MAJĄ PATENT NA CBD. Spidersweb.pl – Healthcann Date: 21 sierpnia 2022 Posted by: admin Category: Bez kategorii WROCŁAWSKI STARTUP CHCE NAMIESZAĆ NA RYNKU KONOPI. MAJĄ PATENT NA CBD. Spidersweb.pl Jednym z najbardziej obecnie rozwijających się rynków jest rynek konopi i CBD. Tylko w Europie ma w tym roku osiągnąć wartość ponad 3 mld do...

At Healthcann S.A., we are developing a portfolio of products within three segments:

- nutraceutical
- pharmaceutical
- intermediates

Each of these segments is developed on the basis of the state-of-the-art technologies being developed for the delivery of cannabinoids to the body.In our business model, we focus on the validation of the offered products under conditions that allow us to obtain data confirming their biological activity and effectiveness. Research is conducted in pharmaceutical methodology, both in terms of pharmacokinetics studies and clinical effect. Which, combined with protected intellectual property rights, increases the attractiveness of the products to users as well as industry and distribution partners.

NASZE MARKI – Healthcann Każdy z tych segmentów rozwijany jest na bazie opracowywanych nowoczesnych technologii dostarczania kannabinoidów do organizmu.W naszym modelu biznesowym koncentrujemy się na walidacji oferowanych produktów w warunkach umożliwiających uzyskanie danych potwierdzających ich aktywność biologi...

TOP 14 most frequently asked questions about cannabis ✅

Answered by dr. Paweł Mituła

KONOPIE TOP 14 najczęściej zadawanych pytań. Odpowiada dr Pawł Mituła | Agnieszka Teodoru Cześć! Dziś na kanale Pokój 420 szybka wymiana pytań z doktorem biotechnologii Pawłem Mitułą. Paweł jest wiceprezesem spółki Healthcann, współtwórcą niesamow...

"Cannabinoid extracts and isolates are likely to grow dramatically in the next years due to client preferences for derivative cannabis products and CBD's use in pharmaceuticals. The therapeutic and restorative properties of cannabidiol are also propelling the industry (CBD). CBD can also be helpful in treating depression, anxiety, stress, diabetes, pain, cancer, and acne. The market is likely to rise over the projected period of 2023-2031 because of the rising use of CBD-based products to treat various medical illnesses, food & drinks, and skin care"

CBD Ingredient Market worth $5.89 billion by 2031 - Exclusive Report by InsightAce Analytic JERSEY CITY, N.J., Dec. 14, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global CBD Ingredient Market By Source(Natural (Ma*****na Based,

Stroke. Therapeutic use of cannabis.

In 2019, strokes were the second leading cause of all deaths worldwide. In comparison, cancers of the lung, bronchus and trachea were "only" the 6th cause of death worldwide. Very worrying is the fact that from 2000 to 2019 there was a nearly 12% increase in stroke mortality. In Poland, stroke caused as many as 32,700 deaths in 2019. According to the same statement, lung, bronchial and tracheal cancers took the lives of 25.8 thousand people.

You can read more about the therapeutic use of cannabis for stroke by clicking on the link.

https://canaticann.eu/2022/05/16/udar-mozgu-terapeutyczne-zastosowanie-konopi/

W imieniu zarządu i zespołu Healthcann S.A. życzymy Państwu spokojnych i radosnych świąt.

See the production line in pharmaceutical standards for CBD 10mg Lozenges.

Zobacz linię produkcyjną w standardach farmaceutycznych dla Pastylek do ssania CBD 10mg #canaticann 🔸 Pastylki do ssania CBD Canaticann to innowacyjny suplement diety zawierający ekstrakt z konopi siewnych. 🔸 16 pastylek canaticann o stężeniu CBD 10 mg na...